Belimumab for systemic lupus erythematosus. 전신홍반루푸스(SLE)에 대한 벨리무맙,
Belimumab for systemic lupus erythematosus (SLE), Only one drug for patients with systemic lupus erythematosus (SLE), belimumab, has been approved on the basis of support from a randomized, placebo-controlled trial, and numerous development programs of immunomodulatory treatments have failed to … Continued